Lessons of a day hospital: Comprehensive assessment of patients with albinism in a European setting
dc.rights.license | open | en_US |
dc.contributor.author | MARTI, A. | |
dc.contributor.author | LASSEAUX, E. | |
dc.contributor.author | EZZEDINE, K. | |
dc.contributor.author | LEAUTE-LABREZE, C. | |
dc.contributor.author | BORALEVI, F. | |
dc.contributor.author | PAYA, C. | |
dc.contributor.author | COSTE, V. | |
hal.structure.identifier | Bordeaux population health [BPH] | |
dc.contributor.author | DEROISSART, Vincent | |
dc.contributor.author | ARVEILER, Benoit | |
dc.contributor.author | TAIEB, A. | |
dc.contributor.author | MORICE-PICARD, F. | |
dc.date.accessioned | 2020-12-07T09:22:09Z | |
dc.date.available | 2020-12-07T09:22:09Z | |
dc.date.issued | 2018-03 | |
dc.identifier.issn | 1755-1471 | en_US |
dc.identifier.uri | https://oskar-bordeaux.fr/handle/20.500.12278/21317 | |
dc.description.abstractEn | Albinism is a rare genetic disease, comprising syndromic and non-syndromic forms. We assessed clinical and genetic characteristics in a prospective evaluation of 64 patients (33 children and 31 adults) seen at a specialized day hospital. Causative genetic mutations were found in TYR (23/64, 35.9%), OCA2 (19/64, 29.7%), TYRP1 (1/64, 1.6%), SLC45A2 (12/64, 18.7%), C10orf11 (1/64, 1.6%), HPS1 (3/64, 4.7%), HPS5 (1/64, 1.5%), HPS6 (1/64, 1.6%) and GPR143 (2/64, 3.1%). Causative mutations remained undetermined for one patient (1.6%). Heterogeneity for hair and skin phenotype was noted across and within the different genotypes. Skin and hair hypopigmentation did not correlate with visual impairment. The diagnosis of unrecognized syndromic forms and of cases of ocular albinism in this prospective and comprehensive series of patients with albinism in a European setting is remarkable. Photoprotection was overall good but not optimal. | |
dc.language.iso | EN | en_US |
dc.subject.en | ISPED | |
dc.title.en | Lessons of a day hospital: Comprehensive assessment of patients with albinism in a European setting | |
dc.title.alternative | Pigment Cell Melanoma Res | en_US |
dc.type | Article de revue | en_US |
dc.identifier.doi | 10.1111/pcmr.12651 | en_US |
dc.subject.hal | Sciences du Vivant [q-bio]/Santé publique et épidémiologie | en_US |
dc.identifier.pubmed | 28976636 | en_US |
bordeaux.journal | Pigment cell & melanoma research | en_US |
bordeaux.page | 318-329 | en_US |
bordeaux.volume | 31 | en_US |
bordeaux.hal.laboratories | Bordeaux Population Health Research Center (BPH) - UMR 1219 | en_US |
bordeaux.issue | 2 | en_US |
bordeaux.institution | Université de Bordeaux | en_US |
bordeaux.team | ISPED | en_US |
bordeaux.peerReviewed | oui | en_US |
bordeaux.inpress | non | en_US |
hal.identifier | hal-03043119 | |
hal.version | 1 | |
hal.date.transferred | 2020-12-07T09:22:13Z | |
hal.export | true | |
bordeaux.COinS | ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Pigment%20cell%20&%20melanoma%20research&rft.date=2018-03&rft.volume=31&rft.issue=2&rft.spage=318-329&rft.epage=318-329&rft.eissn=1755-1471&rft.issn=1755-1471&rft.au=MARTI,%20A.&LASSEAUX,%20E.&EZZEDINE,%20K.&LEAUTE-LABREZE,%20C.&BORALEVI,%20F.&rft.genre=article |
Fichier(s) constituant ce document
Fichiers | Taille | Format | Vue |
---|---|---|---|
Il n'y a pas de fichiers associés à ce document. |